Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)
Condition(s):Atrial FibrillationLast Updated:March 22, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Atrial FibrillationLast Updated:March 22, 2013Completed
Condition(s):Hypertension; Type 2 DiabetesLast Updated:January 30, 2009Completed
Condition(s):Type 1 DiabetesLast Updated:March 17, 2015Terminated
Condition(s):Chemotherapy Induced Systolic DysfunctionLast Updated:March 12, 2024Not yet recruiting
Condition(s):Hypertension Resistant to Conventional TherapyLast Updated:April 5, 2019Completed
Condition(s):Myocardial InfarctionLast Updated:July 15, 2014Completed
Condition(s):Myocardial Infarction; Cardiovascular DiseaseLast Updated:October 7, 2022Completed
Condition(s):Coronary Artery Disease; Angiotensin Converting Enzyme; Angiotensin Receptor Blockers; Cardiopulmonary Bypass; Fibrinolysis; InflammationLast Updated:October 10, 2012Completed
Condition(s):Diabetes; Hypertensive DiseaseLast Updated:September 5, 2016Unknown status
Condition(s):Alport Syndrome; Hereditary Kidney Disease; Pediatric Kidney Disease; Thin Basement Membrane Disease; Familial Benign HematuriaLast Updated:May 24, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.